37490911000001105: Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \UK product\Virtual medicinal product\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \UK product\Virtual therapeutic moiety\Gefitinib\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \UK product\Virtual therapeutic moiety\Gefitinib\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing gefitinib\Gefitinib\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing gefitinib\Gefitinib\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing gefitinib\Product containing gefitinib in oral dose form (medicinal product form)\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing gefitinib\Gefitinib\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing gefitinib\Gefitinib\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing gefitinib\Product containing gefitinib in oral dose form (medicinal product form)\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing gefitinib\Gefitinib\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing gefitinib\Gefitinib\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing gefitinib\Product containing gefitinib in oral dose form (medicinal product form)\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing gefitinib\Gefitinib\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing gefitinib\Gefitinib\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing gefitinib\Product containing gefitinib in oral dose form (medicinal product form)\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing gefitinib in oral dose form (medicinal product form)\Product containing only gefitinib in oral dose form (medicinal product form)\Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet\Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
344541000001110	Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
344551000001113	Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start